Laboratorio Farmaceutico Erfo SpA (FRA:RK7) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RK7 Laboratorio Farmaceutico Erfo SpA FRA:RK7
70 GF Score
Price €0.99
GF Value €1.78
! 3 Warning Signs
View Full Analysis

What is Laboratorio Farmaceutico Erfo SpA FFO per Share?

FFO per Share only applies to REITs.

FRA:RK7
70GF Score
Laboratorio Farmaceutico Erfo SpA FRA:RK7
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Laboratorio Farmaceutico Erfo SpA (FRA:RK7) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued. The current stock price of €0.99 is trading 44.4% below its estimated GF Value™ of €1.78.

Key valuation signals for FRA:RK7:

  • FFO per Share:
  • GF Value™: €1.78 vs. price of €0.99 (44.4% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the FRA:RK7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laboratorio Farmaceutico Erfo SpA Business Description

Other Exchanges ERFO:Italy
Address Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
70GF Score

Get the complete analysis for FRA:RK7

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.99
Price
€1.78
GF Value